Production (Stage)
Cryo-Cell International, Inc.
CCEL
$4.83
$0.030.63%
AMEX
| 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | |
|---|---|---|---|---|---|
| Revenue | 32.10M | 31.99M | 31.84M | 31.64M | 31.37M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 32.10M | 31.99M | 31.84M | 31.64M | 31.37M |
| Cost of Revenue | 7.77M | 7.85M | 11.98M | 12.01M | 12.13M |
| Gross Profit | 24.33M | 24.13M | 19.86M | 19.63M | 19.25M |
| SG&A Expenses | 18.82M | 18.61M | 18.04M | 17.70M | 17.72M |
| Depreciation & Amortization | 642.30K | 483.60K | 568.60K | 655.30K | 876.60K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 28.07M | 28.19M | 31.97M | 31.89M | 32.32M |
| Operating Income | 4.03M | 3.80M | -134.30K | -253.20K | -944.20K |
| Income Before Tax | 2.54M | 2.80M | -12.35M | -12.66M | -13.78M |
| Income Tax Expenses | 2.41M | 2.40M | -3.42M | -3.36M | -4.05M |
| Earnings from Continuing Operations | 0.13 | 0.40 | -8.93 | -9.30 | -9.73 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 128.80K | 402.10K | -8.93M | -9.30M | -9.73M |
| EBIT | 4.03M | 3.80M | -134.30K | -253.20K | -944.20K |
| EBITDA | 4.89M | 4.49M | 646.50K | 619.90K | 171.60K |
| EPS Basic | 0.02 | 0.05 | -1.07 | -1.12 | -1.17 |
| Normalized Basic EPS | 0.16 | 0.16 | -0.06 | -0.05 | -0.14 |
| EPS Diluted | 0.01 | 0.05 | -1.07 | -1.12 | -1.18 |
| Normalized Diluted EPS | 0.16 | 0.15 | -0.07 | -0.05 | -0.14 |
| Average Basic Shares Outstanding | 32.33M | 32.52M | 32.74M | 32.97M | 33.18M |
| Average Diluted Shares Outstanding | 32.67M | 32.80M | 33.02M | 33.19M | 33.29M |
| Dividend Per Share | 0.50 | 0.25 | -- | -- | -- |
| Payout Ratio | 3,137.42% | 502.49% | -- | -- | -- |